REPORT ID 6153

Global Primary Biliary Cirrhosis Drug Market Research Report 2017

Publish Date
25-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the global Primary Biliary Cirrhosis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Primary Biliary Cirrhosis Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Primary Biliary Cirrhosis Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AlbireoPharma
    CymaBay Therapeutics, Inc.
    Dr. Falk Pharma GmbH
    Enanta Pharmaceuticals, Inc.
    GlaxoSmithKline Plc
    Intercept Pharmaceuticals, Inc.
    Johnson & Johnson
    MediGene AG
    NGM Biopharmaceuticals, Inc.
    Virobay Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Budesonide
    FFP-104
    GSK-2330672
    MBX-8025
    NGM-282
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Primary Biliary Cirrhosis Drug Market Research Report 2017
1 Primary Biliary Cirrhosis Drug Market Overview
    1.1 Product Overview and Scope of Primary Biliary Cirrhosis Drug
    1.2 Primary Biliary Cirrhosis Drug Segment by Type (Product Category)
        1.2.1 Global Primary Biliary Cirrhosis Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Primary Biliary Cirrhosis Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Budesonide
        1.2.4 FFP-104
        1.2.5 GSK-2330672
        1.2.6 MBX-8025
        1.2.7 NGM-282
        1.2.8 Others
    1.3 Global Primary Biliary Cirrhosis Drug Segment by Application
        1.3.1 Primary Biliary Cirrhosis Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Primary Biliary Cirrhosis Drug Market by Region (2012-2022)
        1.4.1 Global Primary Biliary Cirrhosis Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Primary Biliary Cirrhosis Drug (2012-2022)
        1.5.1 Global Primary Biliary Cirrhosis Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Primary Biliary Cirrhosis Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Primary Biliary Cirrhosis Drug Market Competition by Manufacturers
    2.1 Global Primary Biliary Cirrhosis Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Primary Biliary Cirrhosis Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Primary Biliary Cirrhosis Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Primary Biliary Cirrhosis Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Primary Biliary Cirrhosis Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Primary Biliary Cirrhosis Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Primary Biliary Cirrhosis Drug Market Competitive Situation and Trends
        2.5.1 Primary Biliary Cirrhosis Drug Market Concentration Rate
        2.5.2 Primary Biliary Cirrhosis Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Primary Biliary Cirrhosis Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Primary Biliary Cirrhosis Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Primary Biliary Cirrhosis Drug Production and Market Share by Region (2012-2017)
    3.3 Global Primary Biliary Cirrhosis Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Primary Biliary Cirrhosis Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Primary Biliary Cirrhosis Drug Consumption by Region (2012-2017)
    4.2 North America Primary Biliary Cirrhosis Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Primary Biliary Cirrhosis Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Primary Biliary Cirrhosis Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Primary Biliary Cirrhosis Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Primary Biliary Cirrhosis Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Primary Biliary Cirrhosis Drug Production, Consumption, Export, Import (2012-2017)

5 Global Primary Biliary Cirrhosis Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Primary Biliary Cirrhosis Drug Production and Market Share by Type (2012-2017)
    5.2 Global Primary Biliary Cirrhosis Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Primary Biliary Cirrhosis Drug Price by Type (2012-2017)
    5.4 Global Primary Biliary Cirrhosis Drug Production Growth by Type (2012-2017)

6 Global Primary Biliary Cirrhosis Drug Market Analysis by Application
    6.1 Global Primary Biliary Cirrhosis Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Primary Biliary Cirrhosis Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Primary Biliary Cirrhosis Drug Manufacturers Profiles/Analysis
    7.1 AlbireoPharma
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 CymaBay Therapeutics, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Dr. Falk Pharma GmbH
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Enanta Pharmaceuticals, Inc.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 GlaxoSmithKline Plc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Intercept Pharmaceuticals, Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Johnson & Johnson
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 MediGene AG
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 MediGene AG Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 NGM Biopharmaceuticals, Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Virobay Inc.
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Primary Biliary Cirrhosis Drug Manufacturing Cost Analysis
    8.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Primary Biliary Cirrhosis Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Primary Biliary Cirrhosis Drug Market Forecast (2017-2022)
    12.1 Global Primary Biliary Cirrhosis Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Primary Biliary Cirrhosis Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Primary Biliary Cirrhosis Drug Price and Trend Forecast (2017-2022)
    12.2 Global Primary Biliary Cirrhosis Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Primary Biliary Cirrhosis Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Primary Biliary Cirrhosis Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Primary Biliary Cirrhosis Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Primary Biliary Cirrhosis Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Primary Biliary Cirrhosis Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Primary Biliary Cirrhosis Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Primary Biliary Cirrhosis Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Primary Biliary Cirrhosis Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer